CMR Molecular Imaging

LumaGEM® Molecular Breast Imaging (MBI) Early Detection from CMR

Solo II High Resolution Breast PET Imaging System (BPI) Treatment Planninc from CMR

Solo II™ BPI- Treatment Planning & Monitoring

  • Extent of Disease for Surgical Planning
  • Monitoring Response to Therapy
  • Monitor for Recurrence
  • Stereo Navigator BPI Biopsy Guidance Accessory

Solo II™ BPI Performance Characteristics

Extent of Disease for Surgical Planning

  • Mammogram shows free silicone
  • Patient unable to undergo MRI
  • Solo II showed implant rupture with mass in L-UOQ and suspicious lymph nodes
  • Mastectomy and ALND confirm 5.5cm IDC with 8/18 lymph nodes +

Images courtesy of Kathy Schilling MD & Maria Victoria Velasquez MD, Christine E. Lynn Women’s Health & Wellness Institute, Center for Breast Care, Boca Raton Regional Hospital, Boca Raton, FL

What Clinicians are Saying

“Breast PET is as sensitive as MRI in the detection of invasive and non-invasive breast cancer, it can identify pathologic atypia better than breast MRI, and can offer quantitative information which may assist in the pathologic discrimination between benign and malignant lesions.”-Kathy Schilling, MD

“I made the decision that I had the time to make Breast PET work and that the reimbursement would cover the cost. Radiation concerns were minimal, and my patients would benefit from using the preferred imaging tool.” –Michael Kinney, MD

Three More States Pass Breast Density Notification Bill


LumaGEM® MBI Patient Experience

  • Gentle immobilization very well tolerated
  • Patients surveyed prefer MBI to mammography
  • Patients who have had MRI prefer MBI
  • All patients surveyed said they would repeat MBI
  • Length of exam well tolerated

LumaGEM® MBI Performance Characteristics

Molecular Breast Imaging in Breast Cancer Screening and Problem Solving– Robin B. Shermis, MD, MPH, Roberta E. Redfern, PhD, Jessica Burns, MD, Haris Kudrolli, PhD

LumaGEM® Molecular Breast Imaging System (MBI) Early Detection

Secondary Screening for Early Detection

  • Evaluation of Unknown Primary
  • Screening Option for High Risk
  • Secondary Screening for Dense Breast Tissue
  • Adjunct to Conventional Imaging
  • Equivocal Conventional Imaging Findings